5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
Evidence-based framework for evaluating a suspected alendronate (Fosamax) efficacy plateau, including adherence and absorption checks, drug holiday criteria, and when to consider switching to another osteoporosis therapy.
A guide to alendronate (Fosamax) dosing, titration schedules, FDA-approved maximums, and the evidence behind dose escalation for osteoporosis management.
A clinical guide to restarting alendronate (Fosamax) after a drug holiday or discontinuation, covering re-titration schedules, dose escalation, BMD monitoring, and when to switch therapies.
A guide to slow alendronate titration for GI-sensitive patients, covering dose escalation schedules, mechanism, evidence from FIT and post-market data, and when to escalate to standard therapy.
A complete clinical guide to the Fosamax (alendronate) standard titration schedule, including FDA-approved doses, dose escalation timing, administration rules, and evidence from FIT and other key trials.